Edition:
United Kingdom

Indoco Remedies Ltd (INRM.NS)

INRM.NS on National Stock Exchange of India

208.40INR
24 Apr 2019
Change (% chg)

Rs-9.20 (-4.23%)
Prev Close
Rs217.60
Open
Rs218.00
Day's High
Rs218.00
Day's Low
Rs207.00
Volume
47,082
Avg. Vol
37,812
52-wk High
Rs238.90
52-wk Low
Rs148.50

Latest Key Developments (Source: Significant Developments)

Indoco Remedies Gets Six Observations After FDA Concludes Audit At Goa Plant I
Monday, 28 Jan 2019 

Jan 28 (Reuters) - Indoco Remedies Ltd ::SAYS USDFA CONCLUDES AUDIT AT INDOCO'S GOA PLANT I.USFDA ISSUED 6 OBSERVATIONS (483S) TO SITE .SAYS NONE OF THE OBSERVATIONS ARE CRITICAL IN NATURE.  Full Article

India's Indoco Remedies Dec-Qtr Profit Falls
Tuesday, 22 Jan 2019 

Jan 23 (Reuters) - Indoco Remedies Ltd ::DEC QUARTER PROFIT 53.4 MILLION RUPEES VERSUS 226.6 MILLION RUPEES YEAR AGO.DEC QUARTER REVENUE FROM OPERATIONS 2.48 BILLION RUPEES VERSUS 2.74 BILLION RUPEES YEAR AGO.SAYS EXPECT THE BUSINESS PERFORMANCE TO START LOOKING UP FROM THE NEXT FINANCIAL YEAR.  Full Article

Indoco Remedies Says Goa Plant Gets 2 Minor Observations From USFDA
Thursday, 22 Nov 2018 

Nov 22 (Reuters) - Indoco Remedies Ltd ::INDOCO REMEDIES LTD - INDOCO GOA PLANT II & III CLEARS USFDA INSPECTION.  Full Article

India's Indoco Remedies Posts Sept-Qtr Loss
Tuesday, 13 Nov 2018 

Nov 13 (Reuters) - Indoco Remedies Ltd ::SEPT QUARTER LOSS 77.9 MILLION RUPEES VERSUS PROFIT 197.6 MILLION RUPEES YEAR AGO.SEPT QUARTER REVENUE FROM OPERATIONS 2.36 BILLION RUPEES VERSUS 2.80 BILLION RUPEES YEAR AGO.  Full Article

Indoco Remedies Gets Statement Of GMP Non-Compliance From UK-MHRA For Goa Plant 1
Wednesday, 25 Apr 2018 

April 25 (Reuters) - Indoco Remedies Ltd ::GOT STATEMENT OF NON-COMPLIANCE AND RESTRICTED GMP CERTIFICATE FOR GOA PLANT 1 FROM UK-MHRA.MHRA STATEMENT SAYS NO EVIDENCE OF PRODUCT HAVING BEEN IMPACTED.SAYS IN INTERIM, MEDICALLY CRITICAL PRODUCTS WILL BE ALLOWED TO BE SUPPLIED FROM EFFECTED FACILITY."INSPECTORATE DOES NOT RECOMMEND THAT THE PRODUCTS ARE RECALLED".WILL HAVE TEMPORARY IMPACT ON CO'S BUSINESS TO EUROPE.  Full Article

Indoco Remedies' API Plant At Patalganga Got Accreditation Renewal From Japanese Regulatory Authorities
Wednesday, 4 Apr 2018 

April 4 (Reuters) - Indoco Remedies Ltd ::SAYS CO'S API PLANT AT PATALGANGA GOT ACCREDITATION RENEWAL FROM JAPANESE REGULATORY AUTHORITIES.ACCREDITATION VALID UNTIL MAY 21, 2023.  Full Article

Indoco Remedies Gets European GMP Certification For Manufacturing Facility In Goa
Thursday, 15 Feb 2018 

Feb 15 (Reuters) - Indoco Remedies Ltd ::GOT EUROPEAN GMP CERTIFICATION FROM REGULATORY AUTHORITY OF HUNGARY FOR MANUFACTURING FACILITY OF NON-STERILE PRODUCTS IN GOA.  Full Article

India's Indoco Remedies Gets 8 Observations From U.S. FDA
Monday, 12 Feb 2018 

Feb 12 (Reuters) - Indoco Remedies Ltd ::GETS 8 OBSERVATIONS FROM U.S. FDA AFTER INSPECTION OF CO'S SOLID DOSAGE PLANT IN GOA.  Full Article

India's Indoco Remedies Dec-Qtr Profit Rises
Thursday, 25 Jan 2018 

Jan 25 (Reuters) - Indoco Remedies Ltd ::DEC QUARTER PROFIT 226.6 MILLION RUPEES VERSUS PROFIT 175.9 MILLION RUPEES YEAR AGO.DEC QUARTER REVENUE FROM OPERATIONS 2.74 BILLION RUPEES VERSUS 2.72 BILLION RUPEES YEAR AGO.  Full Article

India's Indoco Remedies Sept-qtr profit down nearly 11 pct
Tuesday, 7 Nov 2017 

Nov 7 (Reuters) - Indoco Remedies Ltd :Sept quarter profit 197.6 million rupees versus profit of 221.3 million rupees last year.Sept quarter revenue from operations 2.80 billion rupees versus 2.76 billion rupees last year.  Full Article

No consensus analysis data available.